Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection

Tartof, Sara Y; Malden, Deborah E.; Liu, In‐Lu Amy; Sy, Lina S; Lewin, Bruno; Williams, Joshua T.B.; Hambidge, Simon J.; Alpern, Jonathan D.; Daley, Matthew F.; Nelson, Jennifer C.; McClure, David L.; Zerbo, Ousseny; Henninger, Michelle; Fuller, Candace C.; Weintraub, Eric; Saydah, Sharon; Qian, Lei

doi:10.1001/jamanetworkopen.2022.25657

Cited by 36 publications

(36 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Individual conditions within each category were also evaluated. Because of the limited clinical and epidemiologic relevance [ 16 ], we did not look at dementia/cognitive impairment outcomes in individuals <18 years. Outcomes could be ascertained at any time after the acute phase of infection (i.e.…”

Section: Methodsmentioning

confidence: 99%

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Gaudet

Pillay

Saba

et al. 2023

Emerging Microbes & Infections

View full text Add to dashboard Cite

Because of the large number of infected individuals, an estimate of the future burdens of the long-term consequences of SARS-CoV-2 infection is needed. This systematic review examined associations between SARS-CoV-2 infection and incidence of categories of and selected chronic conditions, by age and severity of infection (inpatient vs. outpatient/mixed care). MEDLINE and EMBASE were searched (1 January 2020 to 4 October 2022) and reference lists scanned. We included observational studies from high-income OECD countries with a control group adjusting for sex and comorbidities. Identified records underwent a two-stage screening process. Two reviewers screened 50% of titles/abstracts, after which DistillerAI acted as second reviewer. Two reviewers then screened the full texts of stage one selections. One reviewer extracted data and assessed risk of bias; results were verified by another. Random-effects meta-analysis estimated pooled hazard ratios (HR). GRADE assessed certainty of the evidence. Twenty-five studies were included. Among the outpatient/mixed SARS-CoV-2 care group, there is high certainty of a small-to-moderate increase (i.e. HR 1.26–1.99) among adults ≥65 years of any cardiovascular condition, and of little-to-no difference (i.e. HR 0.75–1.25) in anxiety disorders for individuals <18, 18–64, and ≥65 years old. Among 18–64 and ≥65 year-olds receiving outpatient/mixed care there are probably (moderate certainty) large increases (i.e. HR ≥2.0) in encephalopathy, interstitial lung disease, and respiratory failure. After SARS-CoV-2 infection, there is probably an increased risk of diagnoses for some chronic conditions; whether the magnitude of risk will remain stable into the future is uncertain.

show abstract

Section: Methodsmentioning

confidence: 99%

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Gaudet

Pillay

Saba

et al. 2023

Emerging Microbes & Infections

View full text Add to dashboard Cite

show abstract

“…Individual conditions within each category were also evaluated. Because of the limited clinical and epidemiologic relevance, [16] we did not look at dementia/cognitive impairment outcomes in individuals <18 years. Outcomes could be ascertained at any time after the acute phase of infection (i.e., immediately after discharge in hospitalized patients and ≥4 weeks in outpatients) and no minimum follow-up time was required.…”

Section: Study Eligibilitymentioning

confidence: 99%

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Gaudet

Pillay

Saba

et al. 2023

Preprint

View full text Add to dashboard Cite

Because of the large number of infected individuals, an estimate of the future burdens of the long-term consequences of SARS-CoV-2 infection is needed. This systematic review examined associations between SARS-CoV-2 infection and incidence of categories of and selected chronic conditions, by age and severity of infection (inpatient vs. outpatient/mixed care). MEDLINE and EMBASE were searched (Jan 1, 2020 to Oct 4, 2022) and reference lists scanned. We included observational studies from high-income OECD countries with a control group adjusting for sex and comorbidities. Identified records underwent a two-stage screening process. Two reviewers screened 50% of titles/abstracts, after which DistillerAI acted as second reviewer. Two reviewers then screened the full texts of stage one selections. One reviewer extracted data and assessed risk of bias; results were verified by another. Random-effects meta-analysis estimated pooled hazard ratios (HR). GRADE assessed certainty of the evidence. Twenty-five studies were included. Among the outpatient/mixed SARS-CoV-2 care group, there is high certainty of a small-to-moderate increase (i.e., HR 1.26 to 1.99) among adults ≥65 years of any cardiovascular condition, and of little-to-no difference (i.e., HR 0.75 to 1.25) in anxiety disorders for individuals <18, 18-64, and ≥65 years old. Among 18-64 and ≥65 year-olds receiving outpatient/mixed care there are probably (moderate certainty) large increases (i.e., HR ≥2.0) in encephalopathy, interstitial lung disease, and respiratory failure. After SARS-CoV-2 infection, there is probably an increased risk of diagnoses for some chronic conditions; whether the magnitude of risk will remain stable into the future is uncertain.

show abstract

“… 13 , 28 Tartof et al found COVID-19-associated excess health care utilization in the six months following SARS-CoV-2 infection, but their study did not look at utilization by disability status. 29 Adults with disabilities have more underlying chronic conditions, social vulnerability factors 6 , and pandemic-related behavioral or mental health changes 12 , 7 than adults without disabilities, and associated increased care needs and expenditures for social services. 9 They experience greater challenges than adults without disabilities in accessing health care services 30 (e.g., testing, vaccination, nonpharmaceutical interventions, clinic visits) and might be at higher risk for undiagnosed SARS-CoV-2, leading to missed cases, 13 e.g., PCC in adults with intellectual disabilities.…”

Section: Discussionmentioning

confidence: 99%

Post-COVID conditions and healthcare utilization among adults with and without disabilities—2021 Porter Novelli FallStyles survey

Miller¹,

Feldstein²,

Holbrook³

et al. 2023

Disability and Health Journal

Self Cite

View full text Add to dashboard Cite

Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection

Cited by 36 publications

References 37 publications

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review

Post-COVID conditions and healthcare utilization among adults with and without disabilities—2021 Porter Novelli FallStyles survey

Contact Info

Product

Resources

About